What Bioer Technology does

Bioer Technology (博日科技) is a privately-held Chinese molecular diagnostics company headquartered in Hangzhou, Zhejiang Province, founded in 1995 as a life science R&D group and commercially established in 1998. The company designs, manufactures, and sells an integrated portfolio of PCR and nucleic acid testing instruments, reagents, and consumables serving five end markets: clinical healthcare, life science research, veterinary diagnostics, food safety testing, and biopharmaceutical quality control. Bioer markets through direct sales domestically (with separate sales, technical support, and after-sales teams) and through an international distributor network covering more than 150 countries and regions, with additional support via bonded maintenance services in the Hangzhou Comprehensive Bonded Zone.

Technology centers on PCR thermal cycling, magnetic bead nucleic acid purification, fluorescent quantitative PCR detection, centrifugal microfluidic chip platforms, and digital PCR. Differentiated capabilities include an industry-first high-frequency oscillation nucleic acid extraction method, Ferrotec-customized thermoelectric (Peltier) cooling modules, patented bottom-detection optical systems, disc-type centrifugal microfluidic chips enabling closed-system POCT, and a centrifugal droplet generation approach for digital PCR yielding up to 30,000 effective droplets with greater than 95% sample utilization. The product portfolio spans capital platforms branded QuantGene, LineGene, GenePure, AutoGene, CentriDx, DcentriGene, and PrepFlex, alongside a reagent catalog covering clinical pathogens (influenza A/B, Chikungunya, respiratory pathogens), sample preservation solutions, and veterinary/food-safety assays.

The business model combines capital equipment sales with reagent and consumable pull-through via an explicit instrument + reagent combination sales strategy adopted in 2016. Bioer holds more than 100 patents, invests in excess of 15% of revenue in R&D, has obtained NMPA Class III medical device registration for the CentriDx 200 system, and maintains ISO13485 and ISO9001 certifications across the corporate entity and its Anhui Boori Medical irradiation subsidiary. Manufacturing is anchored at the Hangzhou headquarters (Binjiang District) and at Anhui Boori Medical's Tongling, Anhui facility, which also houses an irradiation sterilization business serving more than 80 customers.

Name

Bioer Technology

Legal name

杭州博日科技股份有限公司

Website

https://bioer.com.cn

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Bioer Technology is a privately-held Chinese molecular diagnostics company that develops and manufactures PCR instruments, automated nucleic acid extraction systems, reagents, and consumables for clinical, research, veterinary, food safety, and biopharma QC customers across 150+ countries.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

akta.pro secondary industries

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices) (AFALAEAK), Release Testing & Batch Certification (QC) (HLAGADAC), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)

Keywords

• Molecular diagnostics instruments
• PCR analyzers
• Nucleic acid extraction
• Fluorescent quantitative PCR
• Life science reagents

Headquarters

HQ city

Hangzhou

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Instruments and Equipment Sales: Sale of PCR instruments, nucleic acid extraction instruments, and automated detection systems as capital equipment purchases. Instruments form the platform on which consumable reagents are consumed, creating recurring revenue linkage.
2. Reagents and Consumables: Sale of molecular diagnostic reagents including PCR detection kits, nucleic acid purification reagents, sample preservation solutions, and consumable lab supplies. High-margin recurring consumables driven by instrument installed base.
3. Instrument + Reagent Combined Package: Since 2016, the company adopted combined instrument and reagent sales strategy, bundling hardware platform sales with reagent supply contracts for customer stickiness.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Bioer Technology designs, manufactures, and sells molecular diagnostics instruments (PCR analyzers, nucleic acid extraction systems, digital PCR platforms, microfluidic chip-based POCT analyzers, sequencing library prep instruments) along with proprietary reagents, sample preservation solutions, PCR consumables, and supporting software. The company serves clinical diagnostics, life science research, veterinary, food safety, and biopharmaceutical QC markets through a B2B sales model in China and a global distributor network.

Product overview

Bioer Technology is a molecular diagnostics company offering an integrated product ecosystem covering PCR instruments, reagents, and consumables for nucleic acid testing. The portfolio includes gene amplifiers (GeneExplorer, LifeECO), real-time fluorescent quantitative PCR analyzers (QuantGene 9600, LineGene series), automated nucleic acid extraction systems (GenePure, AutoGene series), digital PCR platforms (DcentriGene), sample preservation reagents (BSC series), clinical molecular detection reagents (HPV, influenza, respiratory pathogens), and laboratory consumables (PCR tubes, plates, pipette tips). The company also provides supporting software (博日智链APP) for instrument management. This comprehensive仪器+试剂+耗材+原料 (instruments+reagents+consumables+raw materials) solution serves clinical diagnostics, public health testing, animal disease control, food safety, and biopharmaceutical quality control markets.

Differentiator

Problem solved

Functional benefit

Brands

• Bioer: Primary company brand for molecular diagnostics products including PCR instruments, reagents, and consumables.
• CentriDx
• A9600 / FQD-A9600
• PrepFlex
• CentriDx
• GenePure
• QuantGene
• LineGene
• AutoGene

Products and services

• QuantGene 9600 Real-time Fluorescent Quantitative PCR Analyzer High-precision real-time fluorescent quantitative PCR analyzer using thermoelectric cooling technology, 6-zone independent temperature control, and fiber optic top detection for fast, accurate, and stable fluorescence quantitative analysis.
• QuantGene 9600 Ultra Real-time Fluorescent Quantitative PCR Analyzer Next-generation ultra-high-speed real-time fluorescent quantitative PCR analyzer featuring patented TCOne integrated semiconductor cooling chip for faster temperature cycling and improved precision.
• LineGene Mini S Real-time Fluorescent Quantitative PCR Analyzer Portable real-time fluorescent quantitative PCR instrument with rotating optical path design and full-color touchscreen for convenient, flexible operation in laboratory and field settings.
• LineGene K Plus Fluorescent Quantitative PCR Detection System Fluorescence quantitative PCR detection system with large sample capacity, wide temperature range, and multi-detection channels for genomics, forensics, oncology, and clinical diagnostics applications.
• LineGene 9600 Plus Fluorescent Quantitative PCR Detection System Fluorescence quantitative PCR detection system with Ferrotec customized Peltier cooler, automated thermal lid (software-controlled opening/closing, no manual operation), and 6-channel fluorescence detection for high-throughput analysis.
• Fluorescent Quantitative PCR Detection System for Animal Disease Control Fluorescent quantitative PCR detection system designed for animal disease control applications, featuring Ferrotec customized Peltier semiconductor cooler and patented bottom detection mode for faster temperature ramping and improved precision.
• GeneExplorer Gene Amplifier Qualitative gene amplifier with Ferrotec customized semiconductor ceramic temperature control, 8-inch color touchscreen, automatic thermal lid, and noise level ≤40.5dB for routine laboratory DNA amplification.
• LifeECO Gene Amplifier Economical qualitative PCR instrument with 5.7-inch color touchscreen, full steel frame, gradient function with temperature range up to 30°C, and network connectivity via USB or Ethernet, designed for university teaching, lab gene amplification, and production environments.
• GenePure 96 Automated Nucleic Acid Extraction and Purification Instrument High-throughput automated nucleic acid extraction and purification instrument using proprietary high-frequency oscillation technology for improved lysis and elution while preventing aerosol contamination, replacing traditional single magnetic rod or vertical oscillation methods.
• GenePure Pro 9600 Automated Nucleic Acid Extraction and Purification Instrument Automated nucleic acid extraction and PCR system construction instrument integrating sample loading, information entry, nucleic acid extraction, and PCR system configuration in one platform.
• AutoGene 9600 Fully Automated Nucleic Acid Purification and Real-time Fluorescent PCR Analysis System Fully integrated automated nucleic acid testing system handling sample cap removal, information scanning, sample transfer, nucleic acid extraction, PCR system configuration, plate sealing, and PCR amplification in a single workflow, processing 2200+ samples in 24 hours with the first 96 samples completed in 2 hours.
• AutoGene 1600 Fully Automated Nucleic Acid Purification and Real-time Fluorescent PCR Analysis System Integrated PCR analysis system covering sample pretreatment, nucleic acid extraction, and fluorescent quantitative PCR detection, achieving full workflow automation from sample to result with efficient, precise, flexible throughput and safety features.
• CentriDx Fully Automated Nucleic Acid Detection Analyzer Automated nucleic acid testing analyzer based on disc-shaped microfluidic chip technology using centrifugal rotation drive, completing magnetic bead nucleic acid extraction and temperature-cycling nucleic acid amplification within an enclosed microfluidic chip, with up to 6 channels and up to 48-plex detection capability.
• DcentriGene Digital PCR Analysis System Digital PCR analysis system with centrifugal droplet generation technology generating up to 30,000 effective droplets with >95% sample utilization in 3 minutes per 16 samples, featuring 6-color fluorescence channels and absolute quantitative detection.
• PrepFlex Fully Automated Gene Sequencing Library Preparation Instrument Automated gene sequencing library preparation instrument for nucleic acid fragmentation, end repair, adapter ligation, and PCR amplification to improve sequencing library preparation efficiency, with multi-board positions and flexible throughput.
• Rapid Gene Detection System (Portable) Portable gene detection system integrating a 16-well fluorescent quantitative PCR instrument with nucleic acid extraction reagents for field sampling, extraction, amplification, and analysis in a single portable unit.
• ThermoCell Constant Temperature Metal Bath Classic metal bath product with microcomputer control and thermoelectric cooling technology, supporting 5 temperature setpoints for laboratory sample incubation, catalysis, preservation, and mixing applications.
• CountCell Automated Cell Counter Automated cell counter based on advanced cell imaging with deep learning algorithms for accurate cell segmentation and counting using high-definition imaging.
• Sample Preservation Solution BSC82 (Inactivated) Inactivated sample preservation solution containing DNase/RNase inhibitors for room temperature transport and long-term preservation of viral nucleic acids in clinical specimens.
• Sample Preservation Solution BSC85 (Non-inactivated) Non-inactivated preservation system based on Hank's solution for preserving viral proteins and nucleic acids while maintaining virus viability for subsequent isolation culture in clinical and research laboratories.
• Saliva Collector BSC91 Saliva and sputum collection device with integrated preservation solution for collecting, transporting, and preserving samples used in clinical in vitro diagnosis.
• Chikungunya Virus Nucleic Acid Detection Kit (Fluorescent PCR) Real-time fluorescent PCR kit for qualitative detection of Chikungunya virus nucleic acid in human serum, plasma, whole blood, CSF, and mosquito samples, achieving 500 copies/mL sensitivity with zero cross-reactivity against Zika and Dengue viruses.
• Influenza A/B Virus Nucleic Acid Detection Kit Fluorescent PCR kit for qualitative detection of influenza A and B virus nucleic acid, completing amplification in 35 minutes with 200 copies/mL minimum detection limit sensitivity.
• PCR Single Tube (Optical Transparent Flat Cap) Optical transparent flat cap PCR tube with high light transmittance for qPCR fluorescence detection, DNase/RNase-free and pyrogen-free for reliable quantitative PCR workflows.
• PCR 8-Strip Tubes 8-strip PCR tubes with uniform wall thickness for efficient heat conduction and reliable PCR reactions in high-throughput workflows.
• FluxPlate Series Hard-Shell 0.1ml 96-well Full-Skirted PCR Plate Dual-material injection molded 96-well full-skirted PCR plate with polycarbonate frame and polypropylene wells for high-performance qPCR workflows.
• Zhilian APP (Bioer Smart Chain Mobile Application) Mobile application for managing Bioer instruments and displaying data, enabling remote monitoring and control of connected PCR and nucleic acid analysis systems.

Quantifiable outcome

• CentriDx 200 achieved national Class III medical device registration certification
• +6 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Three partnerships are on record, tiered core.

• 温州青峰生物医疗科技有限公司 (Wenzhou Qingfeng Bio-Medical Technology Co., Ltd.)coreStrategic or Co-development Partner · 15 July 2025Bioer Technology and Wenzhou Qingfeng Bio-Medical Technology (incubated by Wenzhou Institute of University of Chinese Academy of Sciences) signed a medical detection instrument joint development agreement at a signing ceremony with total project value exceeding 10 billion RMB. The partnership aims to break the import dependence in high-end detection equipment through joint R&D, combining Bioer's industrialization capability with Qingfeng's frontier research strengths in medical detection instrumentation. The collaboration targets core technology development, product upgrades, and clinical applications of high-end domestic testing equipment.
• 国科温州研究院 (Wenzhou Institute of University of Chinese Academy of Sciences)coreStrategic or Co-development Partner · 1 March 2025Bioer participated in a signing ceremony hosted by Wenzhou Institute of UCAS where the partnership with Qingfeng Bio (incubated by the institute) was formalized. The institute provides frontier scientific research resources and innovation advantages, while Bioer provides industrialization capability and market experience.
• 中国计量大学 (China Jiliang University)coreStrategic or Co-development Partner · 1 January 2024Bioer Technology and China Jiliang University co-established a Joint Laboratory for Biosensing Technology (生物检测技术联合实验室), focusing on collaborative research and development in biosensing technology and high-end medical equipment. This strategic cooperation was recognized with the 2024 Zhejiang Provincial Science and Technology Progress First Prize.

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Cepheid (Danaher): Operates the GeneXpert rapid molecular diagnostic platform widely deployed in hospitals and food safety laboratories globally. Comparable to Bioer's CentriDx disc-microfluidic closed-cartridge POCT architecture and overlaps in target vertical segments including food safety and clinical infectious disease testing.
• Bio-Rad Laboratories: Global life science instrumentation major with the CFX real-time PCR and ddSEQ droplet digital PCR systems. Competes head-on with Bioer's QuantGene/LineGene qPCR and DcentriGene digital PCR offerings in research and clinical markets worldwide.
• QIAGEN: Global leader in sample-preparation (nucleic acid extraction) and molecular diagnostic testing with the Rotor-Gene Q qPCR, QIAcube extraction, and QIASymphony integrated systems — directly mirroring Bioer's GenePure, QuantGene and CentriDx platforms but at global scale with FDA/IVDR approvals.
• Thermo Fisher Scientific (Applied Biosystems): Dominant qPCR/digital PCR instrument franchise (QuantStudio, QuantStudio Absolute Q, KingFisher Flex extraction) with the deepest installed base globally. Sets the technological bar that Bioer competes against across all four vertical segments.
• Roche Diagnostics (cobas / LightCycler): Operates the cobas 6800/8800 molecular systems and the legacy LightCycler qPCR — a global incumbent that Bioer's automated CentriDx and AutoGene platforms target for import substitution in Chinese tertiary hospitals and partnerships seeking alternative suppliers.

Direct peers

• Daan Gene: Sun Yat-sen University-affiliated Chinese molecular diagnostics company with a large PCR/reagent menu for clinical and food safety markets. Comparable to Bioer on combined instruments + reagents commercialization and clinical channel depth.
• Sansure Biotech: Leading Chinese molecular diagnostics company offering PCR/qPCR instruments alongside diagnostic reagents for infectious disease, oncology, and prenatal screening. Directly comparable to Bioer's full-industry-chain instruments + reagents + consumables strategy in clinical molecular diagnostics.
• Autobio Diagnostics: Zhengzhou-based Chinese IVD platform offering chemiluminescence immunoassays, microbiology, and molecular diagnostics. Adjacent competitor in Chinese clinical diagnostics with overlap in molecular diagnostic reagent kits serving hospital channels.
• Liferiver Bio-Tech: Shanghai-based molecular diagnostics company focused on PCR/qPCR instruments and a wide reagent menu for clinical, food safety, and veterinary applications. Highly comparable to Bioer's portfolio breadth across multiple non-clinical verticals.
• Hybio Pharmaceutical: Chinese company producing peptide-based pharmaceutical preparations and diagnostic reagents with growing molecular biology instruments exposure. Comparable diversified diagnostics + reagents mix addressing similar hospital customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BioerTechnology
• Facebookfacebook.com/Bioer-Technology-103601131484238
• LinkedInlinkedin.com/company/bioer

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioer Technology